Aldafermin Completed Phase 1 Trials for Diabetes Mellitus Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01776528Phase 1 SAD and MAD Study of NGM282 in Healthy Adult Participants